Brief: Alphaton Capital Executes Binding Call Option With Immunova
17/02/2026 20:17
Feb 17 (Reuters) - AlphaTON Capital Corp ATON.O: ALPHATON CAPITAL EXECUTES BINDING CALL OPTION TO SELL LEGACY BIOTECH ASSET IOX THERAPEUTICS TO IMMUNOVA ALPHATON CAPITAL CORP - TO RECEIVE CASH PAYMENT AND 10% EQUITY UPON ACQUISITION ALPHATON CAPITAL CORP - TO RECEIVE $100 MILLION MILESTONE PAYMENTS AND ROYALTIES Source text: ID:nGNX5ZmKBx Further company coverage: ATON.O ((((Reuters.Briefs@thomsonreuters.com));))
Recent news on Alpha Compute
See all newsBrief: Alpha Compute Corp. Provides Mid-Q2 2026 Update
Brief: Alpha Compute Ai Gpu Launch Update First Large-Scale Nvidia Blackwell Cluster
Brief: Alpha Compute Appoints Tom Richer To Advisory Board To Accelerate Ai Gpu Compute Infrastructure And Confidential Cloud Strategy
Brief: Alphaton Capital Rebrands As Alpha Compute Corp. To Reflect Its Growing Ai Compute Business
Brief: Alphaton Capital Announces $43 Million Ai Infrastructure And Financing Partnership With Vertical Data